Wu; Herren

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Herren.The latest application filed is for "humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease".

Company Profile

6.59.104

Wu; Herren - Boyds MD
Wu; Herren - Gaithersburg MD
Wu; Herren - Houston TX
Wu; Herren - San Diego CA
Wu; Herren - Germantown MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20210061906 - Damschroder; Melissa ; et al.	2021-03-04
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20200172625 - COYLE; ANTHONY ; et al.	2020-06-04
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20200055944 - Coyle; Anthony ; et al.	2020-02-20
Stabilized angiopoietin-2 antibodies and uses thereof Grant 10,329,345 - Bedian , et al.	2019-06-25
Anti-IFNAR1 antibodies with reduced Fc ligand affinity Grant 10,301,390 - Coyle , et al.	2019-05-28
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20180273621 - Damschroder; Melissa ; et al.	2018-09-27
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20180244791 - Coyle; Anthony ; et al.	2018-08-30
Anti-IFNAR1 antibodies with reduced Fc ligand affinity Grant 9,988,459 - Coyle , et al. June 5, 2	2018-06-05
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20180118839 - COYLE; ANTHONY ; et al.	2018-05-03
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Grant 9,896,505 - Damschroder , et al. February 20, 2	2018-02-20
Cysteine engineered antibodies for site-specific conjugation App 20170183414 - Dimasi; Nazzareno ; et al.	2017-06-29
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20170174756 - BEDIAN; VAHE ; et al.	2017-06-22
Humanized Anti-factor D Antibodies And Uses Thereof App 20170166630 - An; Ling-Ling ; et al.	2017-06-15
Human Anti Il-6 Antibodies With Extended In Vivo Half-life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20170101468 - Bowen; Michael ; et al.	2017-04-13
Cell display of antibody libraries Grant 9,567,389 - Gao , et al. February 14, 2	2017-02-14
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20160145335 - Damschroder; Melissa ; et al.	2016-05-26
Humanized Anti-Factor D Antibodies And Uses Thereof App 20160002353 - An; Ling-Ling ; et al.	2016-01-07
Humanized Anti-Factor D Antibodies And Uses Thereof App 20160002352 - An; Ling-Ling ; et al.	2016-01-07
Humanized Anti-Factor D Antibodies And Uses Thereof App 20150376295 - An; Ling-Ling ; et al.	2015-12-31
Protein scaffolds Grant 9,176,129 - Wu , et al. November 3, 2	2015-11-03
High affinity, anti-human IgE antibodies Grant 9,156,908 - Singh , et al. October 13, 2	2015-10-13
Humanized anti-CD19 antibodies Grant 8,883,992 - Damschroder , et al. November 11, 2	2014-11-11
Human Anti Il-6 Antibodies With Extended In Vivo Half-life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20140302058 - Bowen; Michael ; et al.	2014-10-09
Humanized Anti-Factor D Antibodies And Uses Thereof App 20140303355 - An; Ling-Ling ; et al.	2014-10-09
HIGH AFFINITY, ANTI-HUMAN IgE ANTIBODIES App 20140295494 - Singh; Sanjaya ; et al.	2014-10-02
Crystals and structure of a human IgG Fc variant with enhanced FcRn binding Grant 8,775,090 - Oganesyan , et al. July 8, 2	2014-07-08
Modulation Of Antibody Effector Function By Hinge Domain Engineering App 20140171623 - Dall'Acqua; William ; et al.	2014-06-19
Molecules With Extended Half-Lives And Uses Thereof App 20140170142 - LUBMAN; OLGA ; et al.	2014-06-19
Methods of detecting factor D with anti-factor D antibodies Grant 8,753,826 - An , et al. June 17, 2	2014-06-17
Protein Scaffolds App 20140141994 - Wu; Herren ; et al.	2014-05-22
Modulation of antibody effector function by hinge domain engineering Grant 8,697,396 - Dall'Acqua , et al. April 15, 2	2014-04-15
Protein scaffolds Grant 8,633,297 - Wu , et al. January 21, 2	2014-01-21
High affinity, anti-human IgE antibodies Grant 8,604,171 - Singh , et al. December 10, 2	2013-12-10
Multispecific Epitope Binding Proteins And Uses Thereof App 20130295098 - Wu; Herren ; et al.	2013-11-07
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20130280251 - Bedian; Vahe ; et al.	2013-10-24
Recombinant IL-9 Antibodies And Uses Thereof App 20130273071 - Reed; Jennifer Lynne ; et al.	2013-10-17
Cell Display Of Antibody Libraries App 20130231463 - GAO; CHANGSHOU ; et al.	2013-09-05
Stabilized angiopoietin-2 antibodies and uses thereof Grant 8,507,656 - Bedian , et al. August 13, 2	2013-08-13
Recombinant IL-9 antibodies and uses thereof Grant 8,481,037 - Reed , et al. July 9, 2	2013-07-09
Humanized Anti-Factor D Antibodies And Uses Thereof App 20130171070 - An; Ling-Ling ; et al.	2013-07-04
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20130115657 - Damschroder; Melissa ; et al.	2013-05-09
Mutant antibody Fc domains and fusion proteins thereof Grant 8,409,568 - Gao , et al. April 2, 2	2013-04-02
Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells Grant 8,404,236 - Wu , et al. March 26, 2	2013-03-26
HIGH AFFINITY, ANTI-HUMAN IgE ANTIBODIES App 20130052202 - Singh; Sanjaya ; et al.	2013-02-28
Humanized anti-factor D antibodies and uses thereof Grant 8,372,403 - An , et al. February 12, 2	2013-02-12
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Grant 8,323,653 - Damschroder , et al. December 4, 2	2012-12-04
Integrated approach for generating multidomain protein therapeutics Grant 8,309,690 - Allan , et al. November 13, 2	2012-11-13
Humanized Anti-factor D Antibodies And Uses Thereof App 20120230985 - AN; LING-LING ; et al.	2012-09-13
High affinity, anti-human IgE antibodies Grant 8,252,284 - Singh , et al. August 28, 2	2012-08-28
Method Of Identifying Membrane Ig Specific Antibodies And Use Thereof For Targeting Immunoglobulin-Producing Precursor Cells App 20120141463 - Wu; Herren ; et al.	2012-06-07
Nucleic acids encoding anti-factor D antibodies Grant 8,193,329 - An , et al. June 5, 2	2012-06-05
Molecules With Extended Half-lives And Uses Thereof App 20120134984 - Lubman; Olga ; et al.	2012-05-31
Ultra High Affinity Neutralizing Antibodies App 20120135006 - Young; James F. ; et al.	2012-05-31
Methods of treating with anti-factor D antibodies Grant 8,187,604 - An , et al. May 29, 2	2012-05-29
Recombinant Il-9 Antibodies And Uses Thereof App 20120109097 - Reed; Jennifer Lynne ; et al.	2012-05-03
High affinity antibodies against HMGB1 and methods of use thereof Grant 8,153,131 - Wu , et al. April 10, 2	2012-04-10
High potency recombinant antibodies and method for producing them Grant 8,153,133 - Young , et al. April 10, 2	2012-04-10
Methods Of Administering / Dosing Anti-rsv Antibodies For Prophylaxis And Treatment App 20120070447 - YOUNG; JAMES F. ; et al.	2012-03-22
Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells Grant 8,137,670 - Wu , et al. March 20, 2	2012-03-20
High affinity antibodies against HMGB1 and methods of use thereof Grant 8,129,130 - Wu , et al. March 6, 2	2012-03-06
Modulation Of Antibody Effector Function By Hinge Domain Engineering App 20120046450 - Dall'Acqua; William ; et al.	2012-02-23
Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20120034212 - Bowen; Michael ; et al.	2012-02-09
Humanized anti-factor D antibodies Grant 8,067,002 - An , et al. November 29, 2	2011-11-29
High Affinity Antibodies Against HMGB1 and Methods of Use Thereof App 20110287023 - Wu; Herren ; et al.	2011-11-24
CRYSTALS AND STRUCTURE OF A HUMAN IgG Fc VARIANT WITH ENHANCED FcRn BINDING App 20110288276 - Oganesyan; Vaheh ; et al.	2011-11-24
Toxin Conjugated Eph Receptor Antibodies App 20110280892 - Kinch; Michael S. ; et al.	2011-11-17
Modulation of antibody effector function by hinge domain engineering Grant 8,008,443 - Dall'Acqua , et al. August 30, 2	2011-08-30
Humanized Anti-factor D Antibodies And Uses Thereof App 20110165622 - AN; LING-LING ; et al.	2011-07-07
Methods Of Preventing And Treating Rsv Infections And Related Conditions App 20110158985 - LOSONSKY; GENEVIEVE ; et al.	2011-06-30
High affinity antibodies against HMGB1 and methods of use thereof Grant 7,964,706 - Wu , et al. June 21, 2	2011-06-21
Humanized Anti-factor D Antibodies And Uses Thereof App 20110123528 - An; Ling-Ling ; et al.	2011-05-26
CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT App 20110091992 - Dall'Acqua; William ; et al.	2011-04-21
Antibody Library Display By Yeast Cell Plasma Membrane App 20110076752 - Wu; Herren ; et al.	2011-03-31
Hinge Domain Engineering App 20110077383 - Dall'Acqua; William ; et al.	2011-03-31
High Affinity, Anti-human Ige Antibodies App 20110064725 - Singh; Sanjaya ; et al.	2011-03-17
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20110059078 - Coyle; Anthony ; et al.	2011-03-10
C/CLP Antagonists And Methods Of Use Thereof App 20110059100 - Reed; Jennifer L. ; et al.	2011-03-10
Stabilized Angiopoietin-2 Antibodies And Uses Thereof App 20110044998 - Bedian; Vahe ; et al.	2011-02-24
Cysteine Engineered Antibodies For Site-Specific Conjugation App 20110033378 - Dimasi; Nazzareno ; et al.	2011-02-10
Methods of Treating RSV Infections And Related Conditions App 20110008329 - Krishnan; Subramaniam ; et al.	2011-01-13
Cell Display Of Antibody Libraries App 20100331208 - GAO; Changshou ; et al.	2010-12-30
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Grant 7,847,082 - Young , et al. December 7, 2	2010-12-07
Protein Scaffolds App 20100298541 - Wu; Herren ; et al.	2010-11-25
Ultra High Affinity Neutralizing Antibodies App 20100266614 - YOUNG; James F. ; et al.	2010-10-21
High Potency Recombinant Antibodies And Method For Producing Them App 20100239574 - YOUNG; JAMES F. ; et al.	2010-09-23
Multispecific Epitope Binding Proteins And Uses Thereof App 20100233173 - WU; Herren ; et al.	2010-09-16
Cell display of antibody libraries Grant 7,790,655 - Gao , et al. September 7, 2	2010-09-07
Framework-Shuffling Of Antibodies App 20100216975 - WU; Herren ; et al.	2010-08-26
EPH RECEPTOR Fc VARIANTS WITH ENHANCED ANTIBODY DEPENDENT CELL-MEDIATED CYTOTOXICITY ACTIVITY App 20100203045 - Wu; Herren ; et al.	2010-08-12
High Potency Recombinant Antibodies, Methods For Producing Them And Use In Cancer Therapy App 20100166746 - Chowdhury; Partha ; et al.	2010-07-01
Ultra high affinity neutralizing antibodies Grant 7,740,851 - Young , et al. June 22, 2	2010-06-22
Molecules With Reduced Half-lives, Compositions And Uses Thereof App 20100143254 - Dall'Acqua; William ; et al.	2010-06-10
Increasing The Production Of Recombinant Antibodies In Mammalian Cells By Site-Directed Mutagenesis App 20100145028 - DALL'ACQUA; William ; et al.	2010-06-10
Integrated Approach For Generating Multidomain Protein Therapeutics App 20100105873 - Allan; Christian ; et al.	2010-04-29
Methods Of Preventing And Treating Rsv Infections And Related Conditions App 20100098708 - Losonsky; Genevieve ; et al.	2010-04-22
High Affinity Antibodies Against HMGB1 and Methods Of Use Thereof App 20100061987 - Wu; Herren ; et al.	2010-03-11
.alpha.v.beta.3-specific antibodies Grant 7,667,007 - Huse , et al. February 23, 2	2010-02-23
Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity Grant 7,659,374 - Wu , et al. February 9, 2	2010-02-09
Molecules with extended half-lives, compositions and uses thereof Grant 7,658,921 - Dall'Acqua , et al. February 9, 2	2010-02-09
Methods Of Administering/dosing Anti-rsv Antibodies For Prophylaxis And Treatment App 20100028948 - Young; James F. ; et al.	2010-02-04
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Grant 7,635,568 - Young , et al. December 22, 2	2009-12-22
Toxin Conjugated Eph Receptor Antibodies App 20090304721 - Kinch; Michael S. ; et al.	2009-12-10
Humanization Of Antibodies App 20090297514 - WU; Herren ; et al.	2009-12-03
High affinity antibodies against HMGB1 and methods of use thereof Grant 7,585,504 - Wu , et al. September 8, 2	2009-09-08
Modulation Of Antibody Effector Function By Hinge Domain Engineering App 20090221803 - Dall'Acqua; William ; et al.	2009-09-03
Affinity Optimized Epha2 Agonistic Antibodies And Methods Of Use Thereof App 20090220527 - Damschroder; Melissa ; et al.	2009-09-03
High Affinity Antibodies Against Hmgb1 And Methods Of Use Thereof App 20090169546 - Wu; Herren ; et al.	2009-07-02
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Grant 7,553,489 - Young , et al. June 30, 2	2009-06-30
Multispecific Epitope Binding Proteins And Uses Thereof App 20090155275 - WU; Herren ; et al.	2009-06-18
Method of Identifying Membrane Ig Specific Antibodies and Use Thereof for Targeting Immunoglobulin-Producing Precursor Cells App 20090130111 - Wu; Herren ; et al.	2009-05-21
High affinity anti-human IgE antibodies Grant 7,531,169 - Singh , et al. May 12, 2	2009-05-12
Recombinant Il-9 Antibodies And Uses Thereof App 20090047277 - REED; Jennifer Lynne ; et al.	2009-02-19
Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same App 20090023900 - Huse; William D. ; et al.	2009-01-22
Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof App 20080311122 - Wu; Herren ; et al.	2008-12-18
Molecules with extended half-lives, compositions and uses thereof App 20080181887 - Dall-Acqua; William ; et al.	2008-07-31
Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20080138336 - Damschroder; Melissa ; et al.	2008-06-12
Humanized Anti-Factor D Antibodies and Uses Thereof App 20080118506 - An; Ling-Ling ; et al.	2008-05-22
Methods of inhibiting .alpha..sub.v.beta..sub.3-mediated binding with .alpha..sub.v.beta..sub.3-specific antibodies Grant 7,371,382 - Huse , et al. May 13, 2	2008-05-13
Recombinant IL-9 antibodies Grant 7,354,584 - Reed , et al. April 8, 2	2008-04-08
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Grant 7,323,172 - Young , et al. January 29, 2	2008-01-29
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment App 20070196916 - Young; James F. ; et al.	2007-08-23
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Grant 7,229,619 - Young , et al. June 12, 2	2007-06-12
Cell display of antibody libraries App 20070111260 - Gao; Changshou ; et al.	2007-05-17
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Grant 7,179,900 - Young , et al. February 20, 2	2007-02-20
Methods of optimizing antibody variable region binding affinity Grant 7,175,996 - Watkins , et al. February 13, 2	2007-02-13
High affinity anti-human ige antibodies App 20060251644 - Wu; Herren ; et al.	2006-11-09
Method for generating high affinity antibodies App 20060234296 - Singh; Sanjaya ; et al.	2006-10-19
Framework-shuffling of antibodies App 20060228350 - Wu; Herren ; et al.	2006-10-12
Methods of preventing and treating RSV infections and related conditions App 20060115485 - Losonsky; Genevieve ; et al.	2006-06-01
High affinity antibodies against HMGB1 and methods of use thereof App 20060099207 - Wu; Herren ; et al.	2006-05-11
Ultra high throughput capture lift screening methods App 20060094062 - Wu; Herren ; et al.	2006-05-04
Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity App 20060040325 - Wu; Herren ; et al.	2006-02-23
EPH receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity App 20060039904 - Wu; Herren ; et al.	2006-02-23
Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis App 20060019342 - Dall'Acqua; William ; et al.	2006-01-26
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment App 20050196749 - Young, James F. ; et al.	2005-09-08
Periplasmic expression of antibodies using a single signal sequence App 20050181479 - Dall'Acqua, William ; et al.	2005-08-18
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment App 20050147616 - Young, James F. ; et al.	2005-07-07
Heteromeric variable regions with unvaried human framework regions App 20050064438 - Huse, William D. ; et al.	2005-03-24
Humanization of antibodies App 20050048617 - Wu, Herren ; et al.	2005-03-03
Humanization of antibodies App 20050042664 - Wu, Herren ; et al.	2005-02-24
Methods of optimizing antibody variable region binding affinity Grant 6,849,425 - Huse , et al. February 1, 2	2005-02-01
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment App 20050002926 - Young, James F. ; et al.	2005-01-06
Fce fusion proteins for treatment of allergy and asthma App 20040198961 - An, Ling-Ling ; et al.	2004-10-07
Ultra high affinity neutralizing antibodies App 20040131609 - Young, James F. ; et al.	2004-07-08
Ultra high affinity neutralizing antibodies Grant 6,656,467 - Young , et al. December 2, 2	2003-12-02
Anti- alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use App 20030166872 - Huse, William D. ; et al.	2003-09-04
Methods of optimizing antibody variable region binding affinity App 20030120044 - Huse, William D. ; et al.	2003-06-26
Anti-.alpha.v.beta.3 recombinant human antibodies and nucleic acids encoding same Grant 6,531,580 - Huse , et al. March 11, 2	2003-03-11
Methods for identifying ligand specific binding molecules App 20030044772 - Watkins, Jeffry D. ; et al.	2003-03-06
Ultra high affinity neutralizing antibodies App 20020164326 - Young, James F. ; et al.	2002-11-07
High potency recombinant antibodies and method for producing them App 20020098189 - Young, James F. ; et al.	2002-07-25
Antibodies against human CD40 Grant 6,312,693 - Aruffo , et al. November 6, 2	2001-11-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.